Webinars and Symposia

2021 WEBINAR SERIES

Made possible by an unrestricted educational grant from Arvelle Therapeutics

A series of 10 lectures that shall take place at 17:30hrs every two weeks.

Webinars are only available to members of the ILAE British Branch.

2020 WEBINAR SERIES

During 2020 the ILAE ran a successful webinar series, made possible by an unrestricted education grant from Bial Pharma.

Recordings of previous webinars can be found here:

Webinars are free to members of the ILAE British Branch, and a code will be required to access them. For the code, please email the membership office on: members@ilaebritish.org.uk

We are in the process of planning a new set of webinars from February 2021 onwards. More details to follow.

Epilepsy Awareness Day- Purple Day

The ILAE British Branch will be marking Epilepsy Awareness Day – Purple Day on Friday, March 26th with a webinar. 

The webinar will be from 1730hrs-1930hrs.

Programme 

EPILEPSY AND THE CHILD

Professor Helen Cross, Great Ormond Street

WHAT ARE THE CHALLENGES IN EPILEPSY CARE IN THE UK?

Professor Phil Smith, University of Wales, Cardiff 

ADVANCES IN EPILEPSY CARE

Professor Matthew Walker, UCLH/IoN

The session will be chaired by Dr Manny Bagary, Consultant Neuropsychiatrist, Birmingham and Solihull Mental Health NHS Foundation Trust.

Click here to register for the 26th March. Registration is unrestricted, open to all.

SYMPOSIA

After the cancellation of our 2020 Annual Scientific Meeting we have offered to our sponsoring companies the opportunity to send pre-recorded symposia content which will be available to watch on https://ilaebritishsymposia.org.uk

We will put the symposia online as and when they become available. Each symposium will be available online for five months. We have received two symposia from GW and UCB, respectively, details of which are below. 

GW Pharma Symposium

This symposium brings together international experts to discuss the management of patients with GW Cannabidiol in seizures associated with Dravet Syndrome and Lennox-Gastaut Syndrome, in conjunction with clobazam, from ages 2 years and above. This will include sharing clinical experience, considerations for starting and maintaining patients as well as management of adverse events.

The expected outcome of the presentation being that health care professionals would be educated and informed by a group of experts on the use of GW cannabidiol.

Prescribing Information can be found on:  https://www.emcpi.com/pi/37042

UCB Pharma Symposium

We are delighted to invite you to view this UCB sponsored on demand webinar discussing generalised tonic-clonic seizures in epilepsy. 

The session is opened by a presentation from Dr Manuel Toledo, Vall d’Hebron Hospital, Barcelona, where he discusses the burden and unmet need in his talk; ‘How Soon is Soon Enough for Patients with Generalised Tonic-Clonic Seizures?’ 

His presentation is then followed by lively discussion and clinical case presentations from Professor Philippe Ryvlin, Lausanne University Hospital, Switzerland and Professor John Paul Leach, Queen Elizabeth University Hospital, Glasgow, UK. 

We hope you enjoy this 30 minute webinar.

Symposia Registration

Symposia are available free of charge to both members and non-members. However, due to pharmaceutical company regulations these are restricted to professionals working in clinical settings, clinical research or basic science.

To register, and access a link for the videos please follow the link: https://ilaebritishsymposia.org.uk

Please note we will need to check eligibility before sending an access link/code.The ILAE British Branch has received unrestricted educational funds to be able to make these symposia available, and we are very grateful to GW Pharma and UCB Pharma Ltd. for this funding.